Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer

Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer

The use of conventional chemotherapy in conjunction with targeted and immunotherapy drugs has emerged as an option to limit the severity of side effects in patients diagnosed with head and neck cancer (HNC), particularly oropharyngeal cancer (OPC). OPC prevalence has increased exponentially in the p...

Full description

Bibliographic Details
Main Authors: Isis de Araújo Ferreira Muniz, Megan Araujo, Jenna Bouassaly, Fatemeh Farshadi, Mai Atique, Khashayar Esfahani, Paulo Rogerio Ferreti Bonan, Michael Hier, Marco Mascarella, Alex Mlynarek, Moulay Alaoui-Jamali, Sabrina Daniela da Silva
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:International Journal of Molecular Sciences
Subjects:
head and neck cancer
oropharyngeal cancer
clinical trial
chemotherapy
immunotherapy
drug discovery
Online Access:https://www.mdpi.com/1422-0067/25/7/4009

Internet

https://www.mdpi.com/1422-0067/25/7/4009

Similar Items